Canada Oks Use of Cannabis Suppositories But LPs Don’t Supply

This can pose a threat to patients who are new to cannabis, or are physically frail who can use suppositories that can be inserted into the rectum or vagina for a variety of conditions.

Experts in the industry believe that this lack of supply of suppositories by LPs may be due to the fact that they are not readily prepared for this kind of treatment, especially used in this way, and they believe that it will not catch on.

But stats indicate that many people, especially in the European market, will adopt this method of cannabis treatment.

Currently, LPs only have cannabis in the form of a dried flower, oil, or pills. It is believed that once recreational cannabis becomes legal in the country in October, more forms of cannabis can hit the market like creams and even suppositories.

Industry experts also say that government-approved suppositories will be much less potent than those currently available on the illicit market. Health Canada’s new regulations for the cannabis industry will limit rectal and vaginal suppositories, along with orally administered cannabis capsules, to yielding no more than 10 mg of tetrahydrocannabinol (THC) per unit.

In a statement, a Health Canada said these limits are meant “to protect the health and safety of consumers by ensuring that they know how much THC they are consuming per dose and help reduce the risk of accidental overconsumption.”

The use of cannabis suppositories can date back to ancient use in Egypt where researchers have discovered that it was used to aid in childbirth. It was used vaginally even as recent as the 20th century.

It can be used currently for patients undergoing chemo who are suffering from nausea and are unable to ingest capsules orally. It can also be used for women suffering from dysmenorrhea by inserting vaginally to combat their pain.

Hopefully, as cannabis becomes recreationally legalized throughout the country, these different kinds of uses can become more prevalent in medicine and LPs will allow for the distribution of suppositories for patients without the stigma attached to it.